DNDN: Analysis & Opinions

  1. Little Left To Dendreon But The Hope Trade

    May 10, 2013
    Dendreon looks increasingly irrelevant as the medical community moves on from Provenge.
  2. Priority Review for Bayer's Drug - Analyst Blog

    February 14, 2013
    The HealthCare unit of Bayer AG (BAYRY) recently announced that the US Food and Drug Administration (FDA) granted ...
  3. Dendreon Sells Manufacturing Unit - Analyst Blog

    December 27, 2012
    Dendreon Corporation (DNDN) recently sold its immunotherapy manufacturing facility (IMF) to Novartis Pharmaceuticals ...
  4. Loss at DNDN Wider than Expected - Analyst Blog

    November 06, 2012
    Dendreon Corporation (DNDN) reported third quarter 2012 adjusted loss of 86 cents per share, wider than the Zacks ...
  5. Is “Less Bad” As Good As It Gets For Dendreon?

    November 05, 2012
    Dendreon has made progress with its expenses, but the sluggish revenue growth is still the major problem.
  6. Vertex Pharmaceuticals and Other Healthcare Stocks ...

    November 02, 2012
    The Nasdaq remains relatively unchanged, the S&P 500 has decreased 0.2% and the Dow has declined 0.3% after the ...
  7. Stock Market News for October 30, 2012 - Market News

    October 30, 2012
    Hurricane Sandy, one of the biggest storms to hit the U.S., forced the Street to shut operations on Monday. While ...
  8. Dendreon Treads the Neutral Path - Analyst Blog

    October 11, 2012
    We are maintaining our Neutral recommendation on Dendreon Corporation (DNDN) with a target price of $4.75. The stock ...
  9. New Ratings

    October 09, 2012
    New York, May 23rd (TradersHuddle.com) - These are the research analyst new ratings before the market open. ...
  10. The Week Ahead In Healthcare

    August 08, 2012
    The week ahead for healthcare stocks.
  11. Dendreon Misses Estimates, Cuts Jobs - Analyst Blog

    July 31, 2012
    Dendreon Corporation (DNDN) reported second-quarter 2012 loss (including stock-based compensation expense but ...
  12. Biggest Healthcare Sector Movers, Including SHPG

    July 31, 2012
    After the morning's trading, the Nasdaq is trading up 0.4%, the S&P 500 remains relatively unchanged and the Dow is ...
  13. Biggest Healthcare Sector Movers for July 24, 2012, ...

    July 24, 2012
    On a bad day for the market, the Nasdaq has decreased 0.2%, the S&P 500 has declined 0.5% and the Dow is down 0.6%. ...
  14. Good News for Bayer's Pipeline - Analyst Blog

    June 08, 2012
    The HealthCare unit of Bayer (BAYRY) recently announced that its cancer candidate alpharadin fared well in a phase ...
  15. The Trend In Rising Cancer Incidences

    June 05, 2012
    As the world continues to modernize and grow, global cancer incidences are expected to increase exponentially and ...
  16. Company News for May 09, 2012 - Corporate Summary

    May 09, 2012
    "    Generac Holdings Inc. (NYSE:GNRC) rose 25.4% after it posted first quarter earnings per share of $0.96, ...
  17. Revenues Rise at Dendreon - Analyst Blog

    May 08, 2012
    Dendreon Corporation (DNDN) reported first-quarter 2012 loss (including stock-based compensation expense but ...
  18. Countdown Has Begun for 7 Rising Biotechs

    March 13, 2012
    If you're looking for cutting-edge companies that have a chance to triple or quadruple in the coming months and ...
  19. The 10 Must-Know Market Forces for 2012

    February 14, 2012
    For the first time since 2007, investors have multiple ways to succeed this year. Understanding how the lingering ...
  20. BBQ Recovery: Is All The Good News Cooked In?

    January 20, 2012
    The U.S. is seeing a "BBQ recovery" that is slowly but surely cooking along.
Marketplace
Trading Center